BR0008065A - Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose - Google Patents

Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose

Info

Publication number
BR0008065A
BR0008065A BR0008065-9A BR0008065A BR0008065A BR 0008065 A BR0008065 A BR 0008065A BR 0008065 A BR0008065 A BR 0008065A BR 0008065 A BR0008065 A BR 0008065A
Authority
BR
Brazil
Prior art keywords
preparation
medicines
cholestane derivatives
regulate
unsaturated
Prior art date
Application number
BR0008065-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Thorsten Blume
Peter Esperling
Joachim Kuhnke
Christa Hegele-Hartung
Monika Lessl
Original Assignee
Schering Aktiengellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengellschaft filed Critical Schering Aktiengellschaft
Publication of BR0008065A publication Critical patent/BR0008065A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0008065-9A 1999-02-10 2000-02-09 Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose BR0008065A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99250040 1999-02-10
PCT/EP2000/001074 WO2000047604A1 (fr) 1999-02-10 2000-02-09 Derives de cholestane insatures et leur utilisation pour preparer des medicaments destines a reguler la meiose

Publications (1)

Publication Number Publication Date
BR0008065A true BR0008065A (pt) 2001-11-06

Family

ID=8241140

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008065-9A BR0008065A (pt) 1999-02-10 2000-02-09 Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose

Country Status (15)

Country Link
EP (1) EP1150993A1 (fr)
JP (1) JP2002536456A (fr)
KR (1) KR20010101820A (fr)
CN (1) CN1368977A (fr)
AU (1) AU3279700A (fr)
BR (1) BR0008065A (fr)
CA (1) CA2359687A1 (fr)
CZ (1) CZ20012866A3 (fr)
HU (1) HUP0200280A2 (fr)
IL (1) IL143735A0 (fr)
NO (1) NO20013901D0 (fr)
PL (1) PL350557A1 (fr)
SK (1) SK11382001A3 (fr)
WO (1) WO2000047604A1 (fr)
ZA (1) ZA200107387B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
BR9608968A (pt) * 1995-06-23 1999-06-29 Novo Nordisk As Composto e processo para regular meiose em uma célula germinativa de mamífero
JP2001506656A (ja) * 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物

Also Published As

Publication number Publication date
JP2002536456A (ja) 2002-10-29
AU3279700A (en) 2000-08-29
EP1150993A1 (fr) 2001-11-07
WO2000047604A1 (fr) 2000-08-17
NO20013901L (no) 2001-08-10
IL143735A0 (en) 2002-04-21
CZ20012866A3 (cs) 2002-01-16
ZA200107387B (en) 2002-12-06
PL350557A1 (en) 2002-12-16
CN1368977A (zh) 2002-09-11
SK11382001A3 (sk) 2002-01-07
HUP0200280A2 (hu) 2002-07-29
NO20013901D0 (no) 2001-08-10
CA2359687A1 (fr) 2000-08-17
KR20010101820A (ko) 2001-11-14

Similar Documents

Publication Publication Date Title
ES2314200T3 (es) Una combinacion de un antagonista de nmda e inhibidores de esterasa de acetilcolina par ael tratamiento de la enfermedad de alzheimer.
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
BR9508287A (pt) Formulaçao para a aplicaçao por inalaçao
BR9812001A (pt) Composição farmacêutica para combinação de descongestionante piperidinoalcanol
AR029159A1 (es) Preparacion farmaceutica, envase que la contiene y uso en la preparacion de un medicamento util en la terapia de reemplazo hormonal
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
ES2062392T3 (es) Medicamentos que comprenden salmeterol y fluticasona.
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
BR9908488A (pt) Composição farmacêutica de topiramato
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
BR0211198A (pt) Composições farmacêuticas e seu uso
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
BR0012610A (pt) Novo derivado de difenilpiperidina
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
KR970061244A (ko) 치매 치료용 약학 조성물
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]